Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristen E Pauken

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Nature Reviews. Immunology|May 30, 2023
Localization, tissue biology and T cell state - implications for cancer immunotherapyJason M Schenkel, Kristen E Pauken
Annals of the New York Academy of Sciences|February 1, 2011
The role of the PD-1 pathway in autoimmunity and peripheral toleranceBrian T Fife, Kristen E Pauken
Cancer Cell|December 10, 2014
TIGIT and CD226: tipping the balance between costimulatory and coinhibitory molecules to augment the cancer immunotherapy toolkitKristen E Pauken, E John Wherry
Trends in Immunology|March 24, 2015
Overcoming T cell exhaustion in infection and cancerKristen E Pauken, E John Wherry
Cell|November 7, 2015
SnapShot: T Cell ExhaustionKristen E Pauken, E John Wherry
Nature Reviews. Immunology|October 10, 2017
The diverse functions of the PD1 inhibitory pathwayArlene H Sharpe, Kristen E Pauken
Nature Immunology|November 26, 2024
Next-generation combination approaches for immune checkpoint therapySangeeta Goswami, Kristen E Pauken, Linghua Wang, et al.
Cancer Cell|March 21, 2025
Neoadjuvant immune checkpoint therapy: Enabling insights into fundamental human immunology and clinical benefitKristen E Pauken, Omar Alhalabi, Sangeeta Goswami, et al.
Immunoendocrinology (Houston, Tex.)|September 23, 2016
PD-1 pathway-mediated regulation of islet-specific CD4<sup>+</sup> T cell subsets in autoimmune diabetesTijana Martinov, Justin A Spanier, Kristen E Pauken, et al.
Diabetes|April 3, 2013
PD-1, but not PD-L1, expressed by islet-reactive CD4+ T cells suppresses infiltration of the pancreas during type 1 diabetesKristen E Pauken, Marc K Jenkins, Miyuki Azuma, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Nature Reviews. Immunology|May 30, 2023
Localization, tissue biology and T cell state - implications for cancer immunotherapyJason M Schenkel, Kristen E Pauken
Annals of the New York Academy of Sciences|February 1, 2011
The role of the PD-1 pathway in autoimmunity and peripheral toleranceBrian T Fife, Kristen E Pauken
Cancer Cell|December 10, 2014
TIGIT and CD226: tipping the balance between costimulatory and coinhibitory molecules to augment the cancer immunotherapy toolkitKristen E Pauken, E John Wherry
Trends in Immunology|March 24, 2015
Overcoming T cell exhaustion in infection and cancerKristen E Pauken, E John Wherry
Cell|November 7, 2015
SnapShot: T Cell ExhaustionKristen E Pauken, E John Wherry
Nature Reviews. Immunology|October 10, 2017
The diverse functions of the PD1 inhibitory pathwayArlene H Sharpe, Kristen E Pauken
Nature Immunology|November 26, 2024
Next-generation combination approaches for immune checkpoint therapySangeeta Goswami, Kristen E Pauken, Linghua Wang, et al.
Cancer Cell|March 21, 2025
Neoadjuvant immune checkpoint therapy: Enabling insights into fundamental human immunology and clinical benefitKristen E Pauken, Omar Alhalabi, Sangeeta Goswami, et al.
Immunoendocrinology (Houston, Tex.)|September 23, 2016
PD-1 pathway-mediated regulation of islet-specific CD4<sup>+</sup> T cell subsets in autoimmune diabetesTijana Martinov, Justin A Spanier, Kristen E Pauken, et al.
Diabetes|April 3, 2013
PD-1, but not PD-L1, expressed by islet-reactive CD4+ T cells suppresses infiltration of the pancreas during type 1 diabetesKristen E Pauken, Marc K Jenkins, Miyuki Azuma, et al.
Pageof 6